The mRNA expression levels of calpains and their activity in malignant and dysplastic epithelium of the upper respiratory tract

 Background. The calpain proteolytic system plays an important role in the development of cancer. Detection of early cancer in the upper respiratory tract is often challenging, as symptoms are largely non-specific, and most cases are diagnosed at an advanced stage.

Aim. To identify candidate markers of transition from premalignant lesions to invasive carcinoma, we studied mRNA expression levels of CAPN1 and CAPN2 and the total activity of calpains in the tumor tissues of patients with head and neck squamous cell carcinoma (HNSCC) and in the epithelial dysplasia-affected tissues of patients with chronic diseases of the upper respiratory tract.

Materials and methods. The study included 32 patients with HNSCC (Т1-3N0-1М0) and 12 patients with chronic diseases of the upper respiratory system associated with epithelial dysplasia. The expression levels of CAPN1 and CAPN2 were assessed using real-time polymerase chain reaction (PCR). The calpain activity was determined by hydrolysis of the fluorogenic Suc-LLVY-AMC oligopeptide.

Results. The mRNA expression levels of CAPN1 and CAPN2 were respectively 3 and 4 times higher in the tumor tissue of patients with HNSCC than in the tissue of patients with endothelial dysplasia in the upper respiratory tract. The level of calpain activity was 4.4 times higher in patients with HNSCC than in patients with epithelial dysplasia of different severity.

Conclusion. The elevated mRNA expression levels of CAPN1 and CAPN2 and their activity in the tumor tissues of patients with HNSCC compared to patients with chronic respiratory diseases associated with epithelial dysplasia are likely to characterize a high potential for transition from precancerous lesion to cancer. To clarify the role of calpains in the carcinogenesis of HNSCC, further studies of intact tissues using animal models are required.  

1. Leemans C.R., Braakhuis B.J.M., Brakenhoff R.H. The molecular biology of head and neck cancer. Nature Reviews Cancer. 2011; 11 (1): 9–22. DOI: 10.1038/nrc2982.

2. Alsahafi E., Begg K., Amelio I., Raulf N., Lucarelli P., Sauter T., Tavassoli M. Clinical update on head and neck cancer: molecular biology and ongoing challenges. Cell Death Dis. 2019; 10 (8): 540. DOI: 10.1038/s41419-019-1769-9.

3. Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2018 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России; 2019: 250.

4. Фролова И.Г., Чойнзонов Е.Л., Гольдберг В.Е., Чижевская С.Ю., Чернов В.И., Гольдберг А.В., Белевич Ю.В. Лучевые методы исследования в комплексной диагностике лимфогенного метастазирования у больных раком гортани и гортаноглотки. Сибирский онкологический журнал. 2018; 17 (3): 101–108. DOI: 10.21294/1814-4861-2018-17-3-101-108.

5. Trivedi S., Rosen C.A., Ferris R.L. Current understanding of the tumor microenvironment of laryngeal dysplasia and progression to invasive cancer. Curr Opin Otolaryngol. Head Neck Surg. 2016; 24 (2): 121–127. DOI: 10.1097/MOO.0000000000000245.

6. Черемисина О.В., Чойнзонов Е.Л., Панкова О.В., Меньшиков К.Ю. Хронический гиперпластический ларингит как критерий формирования группы риска по раку гортани. Российская оториноларингология. 2013; 63 (2): 84–89.

7. Какурина Г.В., Кондакова И.В., Чойнзонов Е.Л. Компоненты системы деградома в прогрессии плоскоклеточных карцином головы и шеи. Вестник РАМН. 2015; 70 (6): 684–693. DOI: 10.15690/vramn563.

8. Sorimachi H., Hata S., Ono Y. Calpain chronicle – an enzyme family under multidisciplinary characterization. Proc Jpn. Acad. Ser. B Phys. Biol. Sci. 2011; 87 (6): 287– 327. DOI: 10.2183/pjab.87.287.

9. Macqueen D.J., Wilcox A.H. Characterization of the definitive classical calpain family of vertebrates using phylogenetic, evolutionary and expression analyses. Open Biol. 2014; 4 (4): 130219. DOI: 10.1098/rsob.130219.

10. Moretti D., Del Bello B., Allavena G., Maellaro E. Calpains and cancer: Friends or enemies? Archives of Biochemistry and Biophysics. 2014; 564: 26–36. DOI: 10.1016/j.abb.2014.09.018.

11. Suzuki K., Hata S., Kawabata Y., Sorimachi H. Structure, Activation, and Biology of Calpain. Diabetes. 2004; 53 (Sl. 1): S12–S18. DOI: 10.2337/diabetes.53.2007.S12.

12. Ivanova E.V., Kondakova I.V., Spirina L.V., Afanas’ev S.G., Avgustinovich A.V., Cheremisina O.V. Chymotrypsin-Like activity of proteasomes and total calpain activity in gastric and colorectal cancer. Bull. Exp. Biol. Med. 2014; 157 (6): 781–784. DOI: 10.1007/s10517-014-2666-y.

13. Shashova E.E., Kolegova E.S., Zav’yalov A.A., Slonimskaya E.M., Kondakova I.V. Changes in the activity of proteasomes and calpains in metastases of human lung cancer and breast cancer. Bull. Exp. Biol. Med. 2017; 163 (4): 486–489. DOI: 10.1007/s10517-017-3834-7.

14. Zhang S., Deen S., Storr S.J., Chondrou P.S., Nicholls H., Yao A., Rungsakaolert P., Martin S.G. Calpain system protein expression and activity in ovarian cancer. J. Cancer. Res. Clin. Oncol. 2019; 145 (2): 345–361. DOI: 10.1007/s00432-018-2794-2.

15. Livak K.J., Schmittgen T.D. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method. Methods. 2001; 25 (4): 402–408. DOI: 10.1006/meth.2001.1262.

16. Ma D., Fang J., Liu Y., Song J-J., Wang Y-Q., Xia J., Cheng B., Wang Z. High level of calpain1 promotes cancer cell invasion and migration in oral squamous cell carcinoma. Oncology Letters. 2017; 13 (6): 4017–4026. DOI: 10.3892/ol.2017.5970.

17. Слетов А.А., Можейко Р.А. Особенности дифференциальной диагностики рака слизистой оболочки полости рта с использованием специфических маркеров опухолевой прогрессии. Научный альманах. 2017; 28 (2-3): 389–397. DOI: 10.17117/na.2017.02.03.389.

18. Коваль В.Д., Спирина Л.В., Кондакова И.В., Коломиец Л.А., Шпилева О.В. Активность протеасом и кальпаинов при новообразованиях эндометрия. Молекулярная медицина. 2012; (4):45–48.

19. Шашова Е.Е., Дорошенко А.В., Бондарь Л.Н., Слонимская Е.М., Кондакова И.В. Протеасомная и кальпаиновая протеолитические системы при различных молекулярных подтипах рака молочной железы. Сибирский онкологический журнал. 2017; 16 (3): 33–39. DOI: 10.21294/1814-4861-2017-16-3-33-39.